ORAL DOSAGE FORMULATIONS COMPRISING (2S, 3S,5R)-2-(3,5-DIFLUOROPHENYL) -3,5-DIMETHYL-2-MORPHOLINOL AND AN EFFECTIVE STABILIZING AMOUNT OF ALGINIC ACID - Patent 1117407

(19)

(11)

EP 1 117 407 A1

(12)

(43)	Date of publication:
	25.07.2001 Bulletin 2001/30

(21)	Application number: 99947420.8

(22)	Date of filing: 24.09.1999

(51)	International Patent Classification (IPC)⁷: A61K 31/537, A61K 47/36

(86)	International application number:
	PCT/EP9907/117

(87)	International publication number:
	WO 0018/406 (06.04.2000 Gazette 2000/14)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

28.09.1998 US 102112 P

(71)	Applicant: GLAXO GROUP LIMITED
	Greenford, Middlesex UB6 ONN (GB)

(72)	Inventor:
	BALIK, Samuel Bruce Research Triangle Park, NC 27709 (US)

(74)	Representative: Reed, Michael Antony et al
	Intellectual Property DepartmentGlaxo Wellcome plcGlaxo Wellcome HouseBerkeley Avenue Greenford, Middlesex UB6 0NN Greenford, Middlesex UB6 0NN (GB)

(54)	ORAL DOSAGE FORMULATIONS COMPRISING (2S, 3S,5R)-2-(3,5-DIFLUOROPHENYL) -3,5-DIMETHYL-2-MORPHOLINOL AND AN EFFECTIVE STABILIZING AMOUNT OF ALGINIC ACID